Nuravax

United States
Glenwood City, Wisconsin, United States, 92617

Company profile

Nuravax company profile

Nuravax develops and researches on vaccines, preventive solutions and treatment for neurodegenerative disorders. It is based in California, USA.

Business identity

Contact email
[email protected]
Phone number
+16573659397
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
92617
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $3M / 2025-05-05
Investors
1
Lead investors
1
Articles
6

Founders and investors

Lead investors

National Institutes of Health

Investors

National Institutes of Health